Navigation Links
Ajinomoto Group Expands Cysteine Derivatives Production Capacity
Date:7/15/2014

Tokyo, Japan (PRWEB) July 15, 2014

Ajinomoto Co., Inc. (Ajinomoto Co.) has announced that its subsidiary Nippon Protein Co., Ltd. in Japan will increase Cysteine derivatives production capacity during 2014.

Cysteine derivatives are amino acids widely used in various applications such as pharmaceutical products, bread (dough conditioner), flavors and cosmetics. Many Cysteine derivatives from other manufacturers are produced through an extraction process using animal-origin material, such as human hair and bird feathers; however, Ajinomoto Co. has developed a production method by fermentation based on raw material from vegetable sources. Making use of our own technology for producing Cysteine derivatives, Ajinomoto Co. began supplying fermentation-origin products to the market last year.

The demand for fermentation-origin Cysteine derivatives is dramatically increasing as the demand for animal-source products has fallen. Human hair and bird feather extraction methods are losing favor, in part due to the heavy environmental burdens - such as the creation of large amounts of waste water - that result from the process. Accordingly, demand for our fermentation-origin Cysteine derivatives - which is considered sustainable - is surging globally. Ajinomoto Co. is expanding to accommodate this increased demand and will prepare for further expansion to cope with customers’ demand.

Ajinomoto will make the best effort to meet the market requirement by making use of our advantageous fermentation technology.

Read the full story at http://www.prweb.com/releases/Ajinomoto-Expands-/Cysteine-Derivatives/prweb12012952.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Page: 1

Related biology technology :

1. AtheroNova and Maxwell Biotech Group Ratify Agreement to Develop New Atherosclerosis Drug
2. MiMedx Group, Inc. to Present at the 6th Annual Canaccord Genuity Cardiovascular, Aesthetics and Metabolic Disorders Conference
3. BioNeutral Group Receives $400,000 in Equity Financing
4. MiMedx Group Completes $5,000,000 Private Placement
5. Use Biomarkers in Alzheimers Disease Clinical Trials, Says Expert Group
6. MiMedx Group, Inc. Receives CE Certification for Its CollaFix™ Surgical Mesh CD
7. Lend Lease Announces the Appointment of Tom Chapman as Director Operations for the Life Sciences Group in the Atlantic Region
8. Statewide Network of Angel Investor Groups Announced in Alabama
9. Simcere Pharmaceutical Group to Announce Fourth Quarter and Fiscal Year 2011 Financial Results on Wednesday, March 7, 2012
10. Weikang Bio-Technology Group Co., Inc. Is Expected to Achieve the Net Profit of at Least $26 Million
11. MiMedx Group Announces 2011 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , December 8, 2016 ... expanded its customisable SureSeq™ NGS panel range with the launch ... fast and cost-effective study of variants in familial hypercholesterolemia (FH). ... variation (CNV) detection on a single small panel and allows ... content. This includes all exons for LDLR , ...
(Date:12/8/2016)... , ... December 08, 2016 ... ... the commercial launch of flexible packaging for their exceptionally efficient human mesenchymal ... system extends RoosterBio’s portfolio of bioprocess media products engineered to radically streamline ...
(Date:12/8/2016)... PRINCETON, N.J. , Dec. 8, 2016 /PRNewswire/ ... a late-stage biopharmaceutical company focused on developing and ... is an unmet medical need, announced today the ... trial with SGX942 (dusquetide), a first-in-class Innate Defense ... (OM) in head and neck cancer patients undergoing ...
(Date:12/8/2016)... 8, 2016 Savannah River Remediation LLC ... selected NewTechBio,s NT-MAX Lake & Pond Sludge ... bacteria, in conjunction with Hexa Armor/ Rhombo cover ... National Pollutant Discharge Elimination System requirements. ... steady history of elevated pH levels, above 8.5, ...
Breaking Biology Technology:
(Date:12/8/2016)... , Dec. 8, 2016  Singulex, Inc., the ... Counting technology, entered into a license and supply agreement ... science. The agreement provides Singulex access to Thermo Scientific ... Europe is used to diagnose systemic bacterial ... States to aid in assessing the risk ...
(Date:12/7/2016)... , Dec. 7, 2016   Avanade ... successful Formula One teams in history, exploit biometric data ... stop performance and maintain the competitive edge against their ... 2016. Avanade has worked with Williams ... range of biometric data (heart rate, breathing rate, temperature ...
(Date:12/6/2016)... Valencell , the leading innovator in performance biometric ... consecutive year of triple digit growth for its PerformTek ... 360 percent increase in companies who have acquired Valencell ... sales of its wrist and ear Benchmark™ sensor systems, ... hearables for fitness and healthcare applications. ...
Breaking Biology News(10 mins):